Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s surges on entering into strategic collaboration with Gland Pharma
>>
Dr. Reddy’s enters into strategic collaboration with Gland Pharma
>>
Dr Reddys Laboratories gains despite reporting 60% slump in Q2 consolidated net profit
>>
Dr Reddys Laboratories’ Q2 consolidated net slumps 60%
>>
Dr. Reddys Laboratories trades with traction on the bourses
>>
Dr. Reddy’s launches generic version of Abilify tablets in US market
>>
Dr. Reddy’s launches Lamotrigine Orally Disintegrating Tablets in US
>>
Dr. Reddy’s gains on entering into Colombian market to sell cancer drugs
>>
Dr Reddy’s Laboratories enters into Colombian market to sell cancer drugs
>>
Dr. Reddy’s gains on launching generic version of Zemplar Injection in US market
<<
<
94
95
96
...145
>
>>